Lair1, an itim-containing receptor involved in immune disorders and in hematological neoplasms

HIGHLIGHTS

• who: Franu00e7ois Van Laethem and colleagues from the Department of Biological Hematology, CHU Montpellier, Montpellier, France Faculty of Medicine, University of Montpellier, Montpellier, France have published the article: LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms, in the Journal: (JOURNAL) of 17/02/2022
• what: The inhibitory role of LAIR1 in immune regulation has been well documented, but its function during tumorigenesis and tumor progression remains contradictory.
• future: More experiments are needed to validate its potential clinical use as a single therapy or in association with other checkpoint . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.